Goudy Park Capital
3
71M
2
0.33
2
- Areas of investment
Summary
The venture was found in North America in United States. The main department of described Corporate Investor is located in the Chicago.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Therapeutics, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Naurex, Aptinyx. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with more than 10 partakers. Despite the Goudy Park Capital, startups are often financed by PathoCapital, Latterell Venture Partners, Adams Street Partners. The meaningful sponsors for the fund in investment in the same round are PathoCapital, Adams Street Partners, OUP (Osage University Partners). In the next rounds fund is usually obtained by Rock Springs Capital, PathoCapital, Partner Fund Management.
The higher amount of exits for fund were in 2018. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2017. Comparing to the other companies, this Goudy Park Capital performs on 38 percentage points more the average number of lead investments. Deals in the range of 50 - 100 millions dollars are the general things for fund.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 2
- Follow on index
- 0.33
- Investments by industry
- Biopharma (3)
- Biotechnology (3)
- Health Care (2)
- Medical (2)
- Therapeutics (1)
- Investments by region
-
- United States (3)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 280M
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
- Avg. multiplicator
- 3.45
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Aptinyx | 10 May 2016 | Biotechnology, Health Care, Medical, Biopharma | Early Stage Venture | 65M | United States, Illinois |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.